NAA20
Basic information
Region (hg38): 20:20017310-20033655
Previous symbols: [ "NAT5" ]
Links
Phenotypes
GenCC
Source:
- intellectual developmental disorder, autosomal recessive 73 (Limited), mode of inheritance: AR
- intellectual developmental disorder, autosomal recessive 73 (Strong), mode of inheritance: AR
- intellectual developmental disorder, autosomal recessive 73 (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Intellectual developmental disorder, autosomal recessive 73 | AR | Cardiovascular | Among other findings, the condition can include congenital cardiac anomalies, and awareness may allow early intervention and management | Cardiovascular; Craniofacial; Musculoskeletal; Neurologic | 34230638 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (11 variants)
- Intellectual_developmental_disorder,_autosomal_recessive_73 (2 variants)
- not_provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NAA20 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000016100.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | |||||
| missense | 11 | 13 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 1 | 1 | 11 | 1 | 0 |
Highest pathogenic variant AF is 6.9214786e-7
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| NAA20 | protein_coding | protein_coding | ENST00000334982 | 6 | 16540 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.00620 | 0.916 | 125717 | 0 | 31 | 125748 | 0.000123 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.31 | 65 | 102 | 0.635 | 0.00000523 | 1160 |
| Missense in Polyphen | 10 | 24.966 | 0.40055 | 287 | ||
| Synonymous | -0.552 | 42 | 37.7 | 1.11 | 0.00000225 | 334 |
| Loss of Function | 1.52 | 5 | 10.2 | 0.488 | 4.97e-7 | 129 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000350 | 0.000337 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.000693 | 0.000693 |
| European (Non-Finnish) | 0.0000803 | 0.0000791 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000327 | 0.0000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalytic subunit of the NatB complex which catalyzes acetylation of the N-terminal methionine residues of peptides beginning with Met-Asp, Met-Glu, Met-Asn and Met-Gln. Proteins with cell cycle functions are overrepresented in the pool of NatB substrates. Required for maintaining the structure and function of actomyosin fibers and for proper cellular migration. {ECO:0000269|PubMed:18570629}.;
- Pathway
- Metapathway biotransformation Phase I and II
(Consensus)
Recessive Scores
- pRec
- 0.0948
Intolerance Scores
- loftool
- 0.798
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 41.25
Haploinsufficiency Scores
- pHI
- 0.141
- hipred
- N
- hipred_score
- 0.351
- ghis
- 0.595
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.730
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Low | Low |
| Primary Immunodeficiency | Medium | Low | Medium |
| Cancer | Medium | Low | Medium |
Mouse Genome Informatics
- Gene name
- Naa20
- Phenotype
Gene ontology
- Biological process
- N-terminal peptidyl-methionine acetylation
- Cellular component
- nucleus;cytoplasm;cytosol;NatB complex
- Molecular function
- peptide alpha-N-acetyltransferase activity